226490.KS KODEX KOSPI Loading...

Loading chart...
Top Calls
Feed
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
0 selected
All Content✓
Source feeds
Buzzberg Top 50 ✓
All market capsNo capitalization filter✓
200 B and aboveMega✓
10 B to 200 BLarge✓
2 B to 10 BMid✓
0 to 2 BSmall✓
Custom
Enter market cap range in B USD
All directions✓
▲ Long✓
▼ Short✓
⛔ Avoid✓
✂ Close✓
◦ Others✓
Any score✓
LOW+✓
MED+✓
HIGH✓
? ?
00:50
Aug 21
Kim Hyeong-cheol CEO, Kim Hyung-chul Research Institute 815 Money Talk (815머니톡)
US biotech offers defensive growth and cash.
US biotech stocks offer defensive characteristics and strong cash flows, making them an excellent rotational play if the broader tech sector undergoes a correction.
226490.KS 1ST
MED

About 226490.KS Analyst Coverage

Buzzberg tracks 226490.KS (KODEX KOSPI) across 1 sources. 1 bullish vs 0 bearish calls from 1 analysts. Sentiment: predominantly bullish (100%). 1 total trade idea tracked. Past 7 days: 1 bullish. Latest voices: Kim Hyeong-cheol.